https://www.prweb.com/releases/2022/10/prweb18969705.htm
FDA Allows Phase II-B Clinical Trial to Proceed Using Ischemic-Tolerant Mesenchymal Stem Cells to Treat Patients Suffering from Long-COVID
Cell Therapy News/Articles, page-14371
-
- There are more pages in this discussion • 3,453 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.015(1.30%) |
Mkt cap ! $1.304B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.13 | $1.950M | 1.707M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 71883 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 51412 | 22 |
View Market Depth
| Last trade - 14.36pm 22/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |